FDA
FDA Articles
Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments due to his comments.
Published:
Last Updated:
Repros Therapeutics saw its shares take a loss on Wednesday after the company provided a key FDA update.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.
Published:
Last Updated:
Shares of PhaseRx more than doubled on Monday after the company announced that it received a key FDA approval for its rare liver disorder treatment.
Published:
Last Updated:
Amedica Corp. (NASDAQ: AMDA) is watching its shares drop on Tuesday despite receiving mixed news from the U.S. Food and Drug Administration, along with a new appointment to its management team....
Published:
Last Updated:
Oragenics Inc. (NYSEMKT: OGEN) saw its shares practically double late on Monday, and even continue climbing after the trading session ended, following an update from the U.S. Food and Drug...
Published:
Last Updated:
Now that the U.S. presidential election is over and markets have recovered to their highs, there are still some stocks holding back the markets from breaking even higher.
Published:
Last Updated:
Shares of Aurinia Pharmaceuticals saw a handy gain on Wednesday after the company gave an update on its lupus nephritis treatment.
Published:
Last Updated:
The U.S. presidential election is now over and markets have seemingly recovered to just below their highs but there are still some laggards.
Published:
Last Updated:
Gilead Sciences has announced that the FDA has approved its once-a-day treatment for adults with chronic hepatitis B virus infection.
Published:
Last Updated:
Arrowhead Pharmaceuticals shares plummeted early on Wednesday after the company gave an update on its hepatitis B virus treatment.
Published:
Last Updated:
Shares of Ionis Pharmaceuticals and Biogen were on the move Monday morning after the companies announced positive interim results from a late-stage trial.
Published:
Last Updated:
Aurinia Pharmaceuticals shares saw a handy gain on Thursday morning after the company announced plans for a late-stage trial in the treatment of lupus nephritis.
Published:
Last Updated:
Shares of Ariad Pharmaceuticals saw a modest gain early Monday after the company announced a recent FDA decision.
Published:
Last Updated:
Ariad Pharmaceuticals shares were down handily on Monday after JPMorgan downgraded the stock. Also Senator Sanders recently asked about the pricing of its blood cancer drug Iclusig.
Published:
Last Updated: